Alphatec Holdings, Inc. (ATEC) Q4 2025 Earnings Call Transcript

Alphatec Holdings, Inc. (ATEC) Q4 2025 Earnings Call Transcript

Seeking Alpha • 4 hours ago

ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2025, and business highlights. Fourth Quarter and Full-Year 2025 Financial Results Quarter Ended December 31, 2025 Year Ended December 31, 2025 Total revenue $213 million $764 million GAAP gross margin 70% 70% Non-GAAP gross margin 71% 7.

Business Wire • 8 hours ago

Alphatec (ATEC) Q4 Earnings and Revenues Beat Estimates

Alphatec (ATEC) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.23 per share a year ago.

Zacks Investment Research • 3 hours ago

Alphatec (ATEC) Surges 9.5%: Is This an Indication of Further Gains?

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research • Jan 16, 2026

EVP People and Culture Sells ATEC 33K Shares for $679K

Craig E. Hunsaker, EVP, People & Culture at Alphatec Holdings, sold 32,584 shares for a transaction value of $679,050.56 at $20.84 per share on Dec. 10, 2025. The sale represented 2.53% of Hunsaker's direct holdings, reducing his stake from 1,289,142 to 1,256,558 shares.

The Motley Fool • Jan 14, 2026

Alphatec Holdings, Inc. (ATEC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Alphatec Holdings, Inc. (ATEC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 14, 2026

ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion

ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md.

PRNewsWire • Jan 12, 2026

ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results   Fourth Quarter Ended December 31, 2025 Full Year Ended De.

Business Wire • Jan 12, 2026

Alphatec Stock Up 126% as CEO Sells $2 Million in Shares -- Here's What Investors Should Know

Miles Patrick, the CEO of Alphatec Holdings, sold 100,000 shares of the company for about $2.1 million, according to a recent Form 4. This sale represented 1.82% of Miles Patrick's direct holdings, reducing direct ownership to 5.14 million shares.

The Motley Fool • Jan 11, 2026

Is Alphatec Stock a Buy or Sell After Its COO Dumped Nearly 20,000 Shares?

COO Scott Lish sold 19,900 shares for a transaction value of $390,836 on Dec. 16, 2025. The sale reduced direct ownership to 641,432 shares (0.43% of shares outstanding).

The Motley Fool • Dec 27, 2025